Expanded Partnership Will Offer Genetic Testing for AADC Deficiency
https://pixabay.com/en/baby-child-cute-doll-expression-17366/

Expanded Partnership Will Offer Genetic Testing for AADC Deficiency

  As of the end of August 2020, CENTOGENE has collaborated with more than 40 pharmaceutical partners to develop solutions for patients with rare diseases. In a press release from…

Continue Reading Expanded Partnership Will Offer Genetic Testing for AADC Deficiency
New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease
https://pixabay.com/photos/danio-rerio-zebrafish-small-fish-4996610/

New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease

Did you know that zebrafish, a tropical freshwater fish, are being more commonly used to model and study human diseases? Now, says Phys.org, researchers from the Garvan Institute of Medical…

Continue Reading New Genomic DNA Modification in Zebrafish Could Help Us Study Human Disease
Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 
https://pixabay.com/photos/tomato-food-eating-red-vegetable-1205699/

Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 

If you've ever heard the term "levodopa" be discussed, it was probably in regards to Parkinson's disease. Currently, levodopa (L-DOPA) is the most commonly prescribed therapy for patients with Parkinson's.…

Continue Reading Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 
HemoShear & Takeda Partnership Identifies New Drug Target for NASH
source: pixabay.com

HemoShear & Takeda Partnership Identifies New Drug Target for NASH

In a recent press release, biotechnology company HemoShear Therapeutics ("HemoShear") shared that the company, in collaboration with Takeda Pharmaceutical Company Ltd. ("Takeda") identified a novel therapeutic target for nonalcoholic steatohepatitis…

Continue Reading HemoShear & Takeda Partnership Identifies New Drug Target for NASH